Symbols / AIDX Stock $1.37 +0.00% 20/20 Biolabs, Inc.

Healthcare • Medical Devices • United States • NCM
AIDX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Jonathan Cohen
Exch · Country NCM · United States
Market Cap 14.36M
Enterprise Value 14.69M
Income -3.74M
Sales 2.05M
FCF (ttm) -634.03K
Book/sh -0.01
Cash/sh 0.10
Employees —
Insider 10d —
IPO Feb 19, 2026
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 7.02
P/B -114.17
P/C —
EV/EBITDA -4.53
EV/Sales 7.18
Quick Ratio 0.50
Current Ratio 0.60
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.36
EPS next Y —
EPS Growth —
Revenue Growth 0.40%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA -53.92%
ROE -5.03%
ROIC —
Gross Margin 29.56%
Oper. Margin -169.59%
Profit Margin -182.82%
Shs Outstand 10.48M
Shs Float 9.02M
Insider Own 35.17%
Instit Own 0.08%
Short Float 0.39%
Short Ratio 0.48
Short Interest 33.12K
52W High 50.00
vs 52W High -97.26%
52W Low 1.32
vs 52W Low 3.79%
Beta —
Impl. Vol. —
Rel Volume 0.16
Avg Volume 242.26K
Volume 38.05K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $1.37
Price $1.37
Change 0.00%
About

20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$1.37
Latest analyst target
3. DCF / Fair value
$-1.09
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.37
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-11 init Maxim Group — → Buy $5
News
RSS: Latest AIDX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
2.05
+16.71%
1.75
+23.03%
1.42
Operating Revenue
2.05
+16.71%
1.75
+23.03%
1.42
Cost Of Revenue
1.44
+3.49%
1.39
+5.84%
1.32
Reconciled Cost Of Revenue
1.44
+3.49%
1.39
+5.84%
1.32
Gross Profit
0.60
+67.78%
0.36
+230.14%
0.11
Operating Expense
3.94
-34.64%
6.02
-6.94%
6.47
Research And Development
0.59
-53.04%
1.26
-10.46%
1.41
Selling General And Administration
3.34
-29.77%
4.76
-5.96%
5.06
General And Administrative Expense
—
4.76
-5.96%
5.06
Salaries And Wages
—
1.55
+73.79%
0.89
Other Gand A
—
3.21
-23.03%
4.17
Total Expenses
5.38
-27.48%
7.41
-4.78%
7.79
Operating Income
-3.33
+41.16%
-5.66
+11.01%
-6.36
Total Operating Income As Reported
-3.33
+41.33%
-5.68
+13.59%
-6.57
EBITDA
-3.50
+35.14%
-5.40
+12.80%
-6.20
Normalized EBITDA
-3.51
+34.80%
-5.39
+10.02%
-5.99
Reconciled Depreciation
0.08
-42.56%
0.14
-18.85%
0.17
EBIT
-3.58
+35.32%
-5.54
+12.95%
-6.36
Total Unusual Items
0.01
+147.30%
-0.02
+92.18%
-0.21
Total Unusual Items Excluding Goodwill
0.01
+147.30%
-0.02
+92.18%
-0.21
Special Income Charges
0.00
+100.00%
-0.02
+92.18%
-0.21
Impairment Of Capital Assets
0.00
-100.00%
0.02
-92.18%
0.21
Net Income
-3.74
+32.65%
-5.55
+13.14%
-6.39
Pretax Income
-3.74
+32.65%
-5.55
+13.14%
-6.39
Net Non Operating Interest Income Expense
-0.13
-301.74%
0.07
-63.13%
0.18
Interest Expense Non Operating
0.16
+1135.23%
0.01
-54.70%
0.03
Net Interest Income
-0.13
-301.74%
0.07
-63.13%
0.18
Interest Expense
0.16
+1135.23%
0.01
-54.70%
0.03
Interest Income Non Operating
0.02
-73.07%
0.08
-62.00%
0.21
Interest Income
0.02
-73.07%
0.08
-62.00%
0.21
Other Income Expense
-0.27
-741.65%
0.04
+120.17%
-0.21
Other Non Operating Income Expenses
-0.28
-576.67%
0.06
+3033.05%
-0.00
Gain On Sale Of Security
0.01
—
—
Tax Provision
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-3.74
+32.65%
-5.55
+13.14%
-6.39
Net Income From Continuing Operation Net Minority Interest
-3.74
+32.65%
-5.55
+13.14%
-6.39
Net Income From Continuing And Discontinued Operation
-3.74
+32.65%
-5.55
+13.14%
-6.39
Net Income Continuous Operations
-3.74
+32.65%
-5.55
+13.14%
-6.39
Normalized Income
-3.75
+32.32%
-5.54
+10.46%
-6.18
Net Income Common Stockholders
-3.74
+32.65%
-5.55
+13.14%
-6.39
Diluted EPS
—
-0.54
+13.14%
-0.62
Basic EPS
—
-0.54
+13.14%
-0.62
Basic Average Shares
—
10.35
+0.00%
10.35
Diluted Average Shares
—
10.35
+0.00%
10.35
Diluted NI Availto Com Stockholders
-3.74
+32.65%
-5.55
+13.14%
-6.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
4.14
+15.43%
3.58
-43.71%
6.37
Current Assets
1.47
-27.68%
2.03
-52.70%
4.30
Cash Cash Equivalents And Short Term Investments
1.03
-42.49%
1.78
-56.38%
4.09
Cash And Cash Equivalents
1.03
-42.49%
1.78
-56.38%
4.09
Receivables
0.20
+47.82%
0.14
+96.52%
0.07
Accounts Receivable
0.20
+47.82%
0.14
+96.52%
0.07
Gross Accounts Receivable
0.28
+70.70%
0.16
+67.67%
0.10
Allowance For Doubtful Accounts Receivable
-0.08
-176.16%
-0.03
+0.00%
-0.03
Inventory
0.12
+146.41%
0.05
-22.26%
0.06
Prepaid Assets
—
0.07
-16.80%
0.08
Other Current Assets
0.13
+90.28%
0.07
—
Total Non Current Assets
2.67
+71.99%
1.55
-25.02%
2.07
Net PPE
0.66
-25.54%
0.89
-24.50%
1.18
Gross PPE
1.82
+34.76%
1.35
-18.20%
1.65
Accumulated Depreciation
-1.16
-150.17%
-0.46
+2.65%
-0.48
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
0.25
+0.00%
0.25
+0.00%
0.25
Other Properties
1.57
+42.94%
1.10
-21.56%
1.40
Leases
0.01
+0.00%
0.01
+0.00%
0.01
Goodwill And Other Intangible Assets
0.47
-5.16%
0.50
-5.20%
0.53
Other Intangible Assets
0.47
-5.16%
0.50
-5.20%
0.53
Non Current Deferred Assets
1.51
0.00
-100.00%
0.15
Non Current Prepaid Assets
—
0.11
-29.05%
0.15
Other Non Current Assets
0.02
-85.76%
0.16
+149.61%
0.06
Total Liabilities Net Minority Interest
4.16
+99.94%
2.08
-0.07%
2.08
Current Liabilities
2.46
+81.77%
1.36
+33.95%
1.01
Payables And Accrued Expenses
1.65
+130.11%
0.72
+21.24%
0.59
Payables
0.87
+133.29%
0.37
+3.34%
0.36
Accounts Payable
0.87
+133.29%
0.37
+3.34%
0.36
Current Accrued Expenses
0.79
+126.70%
0.35
+48.97%
0.23
Current Debt And Capital Lease Obligation
0.25
+51.21%
0.17
+1.17%
0.16
Current Debt
0.07
—
—
Other Current Borrowings
0.07
—
—
Current Capital Lease Obligation
0.18
+6.18%
0.17
+1.17%
0.16
Current Deferred Liabilities
0.41
-11.81%
0.47
+84.58%
0.25
Current Deferred Revenue
0.41
-11.81%
0.47
+84.58%
0.25
Other Current Liabilities
0.14
—
—
Total Non Current Liabilities Net Minority Interest
1.69
+133.95%
0.72
-32.27%
1.07
Long Term Debt And Capital Lease Obligation
1.11
+64.44%
0.67
-36.95%
1.07
Long Term Debt
0.62
—
0.23
Long Term Capital Lease Obligation
0.49
-27.47%
0.67
-19.74%
0.84
Non Current Deferred Liabilities
0.04
-16.37%
0.05
0.00
Non Current Deferred Revenue
0.04
-16.37%
0.05
0.00
Stockholders Equity
-0.02
-101.28%
1.51
-64.89%
4.29
Common Stock Equity
-0.07
-104.55%
1.46
-65.61%
4.24
Capital Stock
0.10
+6.93%
0.10
+1.20%
0.09
Common Stock
0.05
+12.84%
0.05
+1.05%
0.05
Preferred Stock
0.05
+0.84%
0.05
+1.35%
0.05
Share Issued
10.35
+0.00%
10.35
+0.00%
10.35
Ordinary Shares Number
10.35
+0.00%
10.35
+0.00%
10.35
Additional Paid In Capital
33.13
+7.04%
30.95
+9.94%
28.15
Retained Earnings
-33.25
-12.67%
-29.51
-23.17%
-23.96
Total Equity Gross Minority Interest
-0.02
-101.28%
1.51
-64.89%
4.29
Total Capitalization
0.60
-60.14%
1.51
-66.67%
4.52
Working Capital
-0.99
-246.07%
0.68
-79.35%
3.29
Invested Capital
0.63
-56.98%
1.46
-67.37%
4.47
Total Debt
1.36
+61.83%
0.84
-31.88%
1.23
Capital Lease Obligations
0.66
-20.83%
0.84
-16.32%
1.00
Net Tangible Assets
-0.49
-148.95%
1.01
-73.24%
3.76
Tangible Book Value
-0.54
-156.26%
0.96
-74.17%
3.71
Derivative Product Liabilities
0.54
0.00
—
Other Equity Interest
—
-0.03
—
Preferred Stock Equity
0.05
+0.84%
0.05
+1.35%
0.05
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-1.92
+26.13%
-2.60
+41.99%
-4.48
Cash Flow From Continuing Operating Activities
-1.92
+26.13%
-2.60
+41.99%
-4.48
Net Income From Continuing Operations
-3.74
+32.65%
-5.55
+13.14%
-6.39
Depreciation Amortization Depletion
0.08
-42.56%
0.14
-18.85%
0.17
Depreciation
0.06
-51.02%
0.11
-20.53%
0.14
Amortization Cash Flow
0.02
+0.00%
0.02
-9.22%
0.02
Depreciation And Amortization
0.08
-42.56%
0.14
-18.85%
0.17
Amortization Of Intangibles
0.02
+0.00%
0.02
-9.22%
0.02
Other Non Cash Items
0.28
—
—
Stock Based Compensation
0.52
-76.28%
2.18
+66.88%
1.30
Asset Impairment Charge
0.00
-100.00%
0.02
-92.18%
0.21
Operating Gains Losses
-0.01
—
—
Gain Loss On Investment Securities
-0.01
—
—
Change In Working Capital
0.84
+35.02%
0.62
+174.43%
0.23
Change In Receivables
-0.06
+2.64%
-0.07
-109.54%
0.70
Changes In Account Receivables
-0.06
+2.64%
-0.07
-109.54%
0.70
Change In Inventory
-0.07
-611.34%
0.01
-48.86%
0.03
Change In Prepaid Assets
0.08
-63.86%
0.22
+223.94%
0.07
Change In Payables And Accrued Expense
0.96
+398.08%
0.19
+138.28%
-0.50
Change In Accrued Expense
0.46
+155.69%
0.18
+144.96%
-0.40
Change In Payable
0.50
+4026.75%
0.01
+111.87%
-0.10
Change In Account Payable
0.50
+4026.75%
0.01
+111.56%
-0.10
Change In Other Working Capital
-0.06
-124.01%
0.27
+532.89%
-0.06
Investing Cash Flow
—
0.00
+100.00%
-0.04
Cash Flow From Continuing Investing Activities
—
0.00
+100.00%
-0.04
Net PPE Purchase And Sale
—
0.00
+100.00%
-0.01
Purchase Of PPE
—
0.00
+100.00%
-0.01
Capital Expenditure
—
—
-0.04
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.03
Purchase Of Intangibles
—
0.00
+100.00%
-0.03
Financing Cash Flow
1.16
+296.03%
0.29
+250.91%
-0.19
Cash Flow From Continuing Financing Activities
1.16
+296.03%
0.29
+250.91%
-0.19
Net Issuance Payments Of Debt
0.99
0.00
+100.00%
-0.05
Issuance Of Debt
0.99
0.00
—
Repayment Of Debt
—
0.00
+100.00%
-0.05
Long Term Debt Issuance
0.99
0.00
—
Long Term Debt Payments
—
0.00
+100.00%
-0.05
Net Long Term Debt Issuance
0.99
0.00
+100.00%
-0.05
Net Common Stock Issuance
0.00
0.00
—
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.00
Net Other Financing Charges
-0.02
—
-0.15
Changes In Cash
-0.76
+67.12%
-2.31
+51.14%
-4.72
Beginning Cash Position
1.78
-56.38%
4.09
-53.57%
8.81
End Cash Position
1.03
-42.49%
1.78
-56.38%
4.09
Free Cash Flow
-1.92
+26.13%
-2.60
+42.55%
-4.52
Interest Paid Supplemental Data
0.00
0.00
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
Amortization Of Securities
0.12
+2213.40%
0.00
-4.40%
0.01
Change In Interest Payable
0.04
+435.06%
0.01
-54.12%
0.02
Common Stock Issuance
0.00
0.00
—
Issuance Of Capital Stock
0.20
-32.81%
0.29
0.00
Net Preferred Stock Issuance
0.19
-34.43%
0.29
0.00
Preferred Stock Issuance
0.19
-34.43%
0.29
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category